Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$21.54 - $24.41 $355,948 - $403,375
16,525 Added 41.76%
56,100 $1.27 Million
Q2 2023

Aug 14, 2023

BUY
$12.62 - $24.47 $156,462 - $303,379
12,398 Added 45.62%
39,575 $968,000
Q1 2023

May 15, 2023

SELL
$12.98 - $17.1 $39,264 - $51,727
-3,025 Reduced 10.02%
27,177 $365,000
Q4 2022

Feb 14, 2023

BUY
$13.92 - $17.0 $18,778 - $22,933
1,349 Added 4.68%
30,202 $469,000
Q3 2022

Nov 14, 2022

BUY
$13.36 - $16.75 $385,476 - $483,287
28,853 New
28,853 $433,000

Others Institutions Holding ABCM

About Abcam plc


  • Ticker ABCM
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 229,044,992
  • Description
  • Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...
More about ABCM
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.